Here is What Hedge Funds Think About BiomX Inc. (PHGE)
A whopping number of 13F filings filed with U.S.
Biomx Inc. (PHGE)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | OrbiMed Advisors Samuel Isaly | 1,787,767 | $1,823,522 | 0.03% | |
| 2. | Deerfield Management James E. Flynn | 1,787,610 | $1,823,362 | 0.02% | |
| 3. | Nantahala Capital Management Wilmot B. Harkey And Daniel Mack | 1,730,600 | $1,765,212 | 0.08% | |
| 4. | Ikarian Capital Neil Shahrestani | 893,000 | $910,860 | 0.12% | |
| 5. | AIGH Investment Partners Orin Hirschman | 865,400 | $882,708 | 0.24% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.27 | 3,192 | Officer | 10,914 | 2023-05-22 | Filing | |
| $0.28 | 6,521 | Officer | 7,722 | 2023-05-19 | Filing | |
| $0.27 | 1,201 | Officer | 1,201 | 2023-05-18 | Filing | |
| $0.25 | 348,000 | Large Shareholder | 3,161,489 | 2023-02-27 | Filing | |
| $0.00 | 37,500 | Director | 372,717 | 2021-07-26 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.38 | 24,344 | Large Shareholder | 13,773,653 | 2024-05-15 | Filing | |
| $0.34 | 2,056 | Officer | 0 | 2023-11-29 | Filing | |
| $0.35 | 3,414 | Officer | 2,056 | 2023-11-29 | Filing | |
| $0.40 | 5,444 | Officer | 5,470 | 2023-11-29 | Filing | |
| $0.38 | 1,501 | Other | 2,997,025 | 2022-11-04 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 213,340.2 | $597,353 | 0.01% | |
| 2. | 108,619.1 | $304,133 | 0.31% | |
| 3. | 9,680.5 | $26,331 | 0% | |
| 4. | 4,950 | $13,860 | 0% | |
| 5. | 2,105.6 | $5,896 | 0% |
News See All
Hedge Funds Cautiously Watching BiomX Inc. (PHGE)
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first.